DE60140794D1 - Von casein abgeleitete peptide und deren anwendung für die therapie - Google Patents
Von casein abgeleitete peptide und deren anwendung für die therapieInfo
- Publication number
- DE60140794D1 DE60140794D1 DE60140794T DE60140794T DE60140794D1 DE 60140794 D1 DE60140794 D1 DE 60140794D1 DE 60140794 T DE60140794 T DE 60140794T DE 60140794 T DE60140794 T DE 60140794T DE 60140794 D1 DE60140794 D1 DE 60140794D1
- Authority
- DE
- Germany
- Prior art keywords
- peptides
- casein
- stimulating
- derived
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Marine Sciences & Fisheries (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13483000A IL134830A0 (en) | 2000-03-01 | 2000-03-01 | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
PCT/IL2001/000198 WO2001064234A1 (en) | 2000-03-01 | 2001-03-01 | Casein derived peptides and uses thereof in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60140794D1 true DE60140794D1 (de) | 2010-01-28 |
Family
ID=11073892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60140794T Expired - Lifetime DE60140794D1 (de) | 2000-03-01 | 2001-03-01 | Von casein abgeleitete peptide und deren anwendung für die therapie |
Country Status (21)
Country | Link |
---|---|
US (6) | US20020147144A1 (de) |
EP (1) | EP1261360B1 (de) |
JP (1) | JP2003528827A (de) |
KR (1) | KR20030025907A (de) |
CN (1) | CN1427725A (de) |
AT (1) | ATE451929T1 (de) |
AU (1) | AU782662B2 (de) |
BR (1) | BR0109027A (de) |
CA (1) | CA2401550A1 (de) |
CZ (1) | CZ20022915A3 (de) |
DE (1) | DE60140794D1 (de) |
DK (1) | DK1261360T3 (de) |
EA (3) | EA007217B1 (de) |
HU (1) | HUP0301003A3 (de) |
IL (2) | IL134830A0 (de) |
MX (1) | MXPA02008569A (de) |
NO (1) | NO20024157L (de) |
NZ (1) | NZ521016A (de) |
PL (1) | PL361307A1 (de) |
WO (1) | WO2001064234A1 (de) |
ZA (1) | ZA200206842B (de) |
Families Citing this family (142)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL375113A1 (en) * | 2001-08-30 | 2005-11-28 | Chay 13 Medical Research Group N.V. | Casein derived peptides and uses thereof in therapy |
US20030179916A1 (en) * | 2002-02-06 | 2003-09-25 | Magnuson Terry R. | High-throughput cell identification and isolation method and apparatus |
EP1359157A1 (de) * | 2002-04-29 | 2003-11-05 | Société des Produits Nestlé S.A. | Metalloproteinase-Hemmstoff |
CN102266272B (zh) * | 2002-11-27 | 2012-12-26 | Dmi生物科学公司 | 一种个人护理组合物及其产品 |
GB0313892D0 (en) * | 2003-06-16 | 2003-07-23 | Hannah Res Inst | Control of lactation |
EA200601575A1 (ru) * | 2004-03-01 | 2007-06-29 | Пептера Фармасьютикалс Лтд. | Казеиновые пептиды и их терапевтическое применение |
EP3366138A1 (de) | 2004-03-30 | 2018-08-29 | Monsanto Technology LLC | Verfahren zur bekämpfung von pflanzenpathogenen mit n-phosphonomethylglycin |
WO2005099724A2 (en) * | 2004-04-13 | 2005-10-27 | Parallel Solutions, Inc. | Functionalized water-soluble polyphosphazene and uses thereof as modifiers of biological agents |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9000040B2 (en) * | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
WO2006037080A2 (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Uv cured gel and method of making |
GB0423352D0 (en) | 2004-10-21 | 2004-11-24 | Hannah Res Inst | "Control of mammary cell number" |
MX2007013866A (es) * | 2005-05-02 | 2008-04-07 | Mileutis Ltd | Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos. |
ES2319475B1 (es) * | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
US11266607B2 (en) * | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
EP2447368A3 (de) | 2005-10-04 | 2012-12-26 | Inimex Pharmaceuticals Inc. | Neuartige Peptide zur Behandlung und Prävention von mit dem Immunsystem zusammenhängenden Erkrankungen, einschließlich der Behandlung und Prävention einer Infektion durch Modulierung der angeborenen Immunität |
US20070086958A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Formation of medically useful gels comprising microporous particles and methods of use |
GB2436328A (en) * | 2006-03-22 | 2007-09-26 | Regen Therapeutics Plc | Peptide derived from colostrinin |
EP1998853A1 (de) * | 2006-03-24 | 2008-12-10 | Unilever N.V. | Gesundes nahrungsmittelprodukt |
EP1836906B1 (de) * | 2006-03-24 | 2009-07-01 | Unilever N.V. | Gesundes Nahrungsmittel |
AU2007304847A1 (en) * | 2006-10-04 | 2008-04-10 | Inimex Pharmaceuticals, Inc. | Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
AU2008212127B2 (en) * | 2007-02-05 | 2013-03-28 | National University Of Singapore | Putative cytokinin receptor and methods for use thereof |
US8097712B2 (en) | 2007-11-07 | 2012-01-17 | Beelogics Inc. | Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
EP2255780A1 (de) * | 2008-03-12 | 2010-12-01 | Shiseido Company, Ltd. | Parakeratosehemmer, porenverkleinerungsmittel bzw. mittel zur vermeidung oder verbesserung von rauer haut und zusammensetzung zur anwendung auf der haut damit |
KR101355695B1 (ko) * | 2009-02-06 | 2014-01-27 | 더 프록터 앤드 갬블 캄파니 | 붕괴성 수분-함유 캡슐 |
JP2012523433A (ja) * | 2009-04-10 | 2012-10-04 | アブラクシス バイオサイエンス, エルエルシー | ナノ粒子処方物およびその使用 |
JP5858906B2 (ja) | 2009-05-04 | 2016-02-10 | シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. | 多孔質シリコン薬物溶出粒子 |
WO2010135324A1 (en) * | 2009-05-18 | 2010-11-25 | Monsanto Technology Llc | Use of glyphosate for disease suppression and yield enhancement in soybean |
GB0912481D0 (en) | 2009-07-17 | 2009-08-26 | Reckitt Benckiser Healthcare I | Skincare compositions |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US8962584B2 (en) | 2009-10-14 | 2015-02-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Compositions for controlling Varroa mites in bees |
BR112012015653B1 (pt) * | 2009-12-29 | 2023-09-26 | W.R. Grace & Co. -Conn. | Composição que compreende um material de sílica particulado poroso e película transparente que compreende a mesma |
JP5814265B2 (ja) * | 2010-02-04 | 2015-11-17 | アイエスピー インヴェストメンツ インコーポレイテッドIsp Investments Inc. | 無水日焼け防止処方物用の自己適応ポリマー |
MX2012009632A (es) | 2010-02-18 | 2012-09-28 | Athenix Corp | Genes delta-endotoxinicos axmi221z, axmi222z, axmi223z, axmi224z, axmi225z y metodos para su uso. |
MX2012009634A (es) * | 2010-02-18 | 2012-09-28 | Athenix Corp | Genes delta-endotoxinicos axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, y axmi231 y metodos para sus uso. |
EP2545182B1 (de) | 2010-03-08 | 2017-05-03 | Monsanto Technology LLC | Polynukleotidmoleküle zur genregulierung in pflanzen |
FR2958155B1 (fr) * | 2010-04-02 | 2012-04-20 | Oreal | Composition de decoloration comprenant un sel peroxygene dans une base fortement riche en corps gras |
WO2011137563A1 (en) | 2010-05-07 | 2011-11-10 | Unilever Plc | High solvent content emulsions |
EA033088B1 (ru) | 2010-06-04 | 2019-08-30 | Монсанто Текнолоджи Ллс | Трансгенное событие mon 88302 у вида brassica и способы его применения |
EP2593141B1 (de) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Zusammensetzung und verfahren zur veränderung der geschwindigkeit einer hydrolyse ausgehärteter materialien auf ölbasis |
US8802933B2 (en) * | 2010-08-19 | 2014-08-12 | Pioneer Hi Bred International Inc | Bacillus thuringiensis gene with lepidopteran activity |
US9757374B2 (en) | 2010-10-28 | 2017-09-12 | Aequus Pharmaceuticals Inc. | Aripiprazole compositions and methods for its transdermal delivery |
CA2816203C (en) * | 2010-10-28 | 2017-02-21 | Transdermal Research Pharm Laboratories, Llc | Aripiprazole compositions and methods for its transdermal delivery |
WO2012061377A1 (en) | 2010-11-01 | 2012-05-10 | Psivida Us, Inc. | Bioerodible silicon-based devices for delivery of therapeutic agents |
WO2012170355A2 (en) * | 2011-06-04 | 2012-12-13 | The Texas A&M University System | Potato transformation compositions, systems, methods, microorganisms, and plants |
EP2742059A1 (de) * | 2011-08-12 | 2014-06-18 | Bayer CropScience NV | Schliesszellspezifische expression von transgenen in baumwolle |
US10806146B2 (en) | 2011-09-13 | 2020-10-20 | Monsanto Technology Llc | Methods and compositions for weed control |
US10829828B2 (en) | 2011-09-13 | 2020-11-10 | Monsanto Technology Llc | Methods and compositions for weed control |
AU2012308694B2 (en) | 2011-09-13 | 2018-06-14 | Monsanto Technology Llc | Methods and compositions for weed control |
US10760086B2 (en) | 2011-09-13 | 2020-09-01 | Monsanto Technology Llc | Methods and compositions for weed control |
CN104160028A (zh) | 2011-09-13 | 2014-11-19 | 孟山都技术公司 | 用于杂草控制的方法和组合物 |
US9840715B1 (en) | 2011-09-13 | 2017-12-12 | Monsanto Technology Llc | Methods and compositions for delaying senescence and improving disease tolerance and yield in plants |
MX362812B (es) | 2011-09-13 | 2019-02-13 | Monsanto Technology Llc | Metodos y composiciones para el control de malezas. |
MX342856B (es) | 2011-09-13 | 2016-10-13 | Monsanto Technology Llc | Metodos y composiciones para el control de malezas. |
US9920326B1 (en) | 2011-09-14 | 2018-03-20 | Monsanto Technology Llc | Methods and compositions for increasing invertase activity in plants |
EP2764046B1 (de) * | 2011-10-05 | 2021-04-21 | DuPont Nutrition USA, Inc. | Stabilisatorzusammensetzung aus mikrokristalliner cellulose und carboxymethylcellulose, verfahren zu ihrer herstellung und deren anwendungen |
US9492363B1 (en) * | 2012-01-16 | 2016-11-15 | American Spraytech, L.L.C. | Aerosol sprayable color composition |
US20130195956A1 (en) * | 2012-01-27 | 2013-08-01 | Agile Therapeutics, Inc. | Transdermal Hormone Delivery |
FR2988566B1 (fr) * | 2012-03-28 | 2014-08-08 | Yoplait France | Compositions alimentaires pour stimuler la formation de tissu osseux |
US10240161B2 (en) | 2012-05-24 | 2019-03-26 | A.B. Seeds Ltd. | Compositions and methods for silencing gene expression |
CA2919487A1 (en) * | 2012-08-03 | 2014-02-06 | Msm Innovations, Inc. | Kits using miraculin to reduce salty taste of a liquid composition |
US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US10584381B2 (en) | 2012-08-14 | 2020-03-10 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
CN114891871A (zh) | 2012-08-14 | 2022-08-12 | 10X基因组学有限公司 | 微胶囊组合物及方法 |
US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9617297B2 (en) * | 2012-10-11 | 2017-04-11 | The Regents Of The University Of California | Apoplast wash fluid recovery for improved recombinant endoglucanase extraction in tabacco leaves |
CA2888264A1 (en) | 2012-10-18 | 2014-04-24 | Monsanto Technology Llc | Methods and compositions for plant pest control |
EP2931919B1 (de) | 2012-12-14 | 2019-02-20 | 10X Genomics, Inc. | Verfahren und systeme zur verarbeitung von polynukleotiden |
US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9206436B2 (en) * | 2012-12-20 | 2015-12-08 | Ut-Battelle, Llc | Key gene regulating cell wall biosynthesis and recalcitrance in Populus, gene Y |
UY35251A (es) | 2013-01-01 | 2014-07-31 | Seeds Ltd Ab | MOLÉCULAS DE dsRNA AISLADAS Y MÉTODOS PARA USARLAS PARA SILENCIAR MOLÉCULAS DIANA DE INTERÉS |
US10683505B2 (en) | 2013-01-01 | 2020-06-16 | Monsanto Technology Llc | Methods of introducing dsRNA to plant seeds for modulating gene expression |
US10000767B2 (en) | 2013-01-28 | 2018-06-19 | Monsanto Technology Llc | Methods and compositions for plant pest control |
EP2954065B1 (de) | 2013-02-08 | 2021-07-28 | 10X Genomics, Inc. | Partitionierung und verarbeitung von analyten und andere arten |
US8961680B2 (en) * | 2013-03-08 | 2015-02-24 | Tbf Environmental Technology Inc. | Solvent formulations |
WO2014165108A1 (en) * | 2013-03-12 | 2014-10-09 | Psivida Us, Inc. | Bioerodible silicon-based delivery vehicles for delivery of therapeutic agents |
MX364458B (es) | 2013-03-13 | 2019-04-26 | Monsanto Technology Llc | Métodos y composiciones para el control de malezas. |
AR095233A1 (es) | 2013-03-13 | 2015-09-30 | Monsanto Technology Llc | Métodos y composiciones para el control de malezas |
US20140283211A1 (en) | 2013-03-14 | 2014-09-18 | Monsanto Technology Llc | Methods and Compositions for Plant Pest Control |
WO2014152189A1 (en) * | 2013-03-15 | 2014-09-25 | Maria Beug-Deeb Inc. Dba T&M Associates | Methods and compositions for cleaning and disinfecting surfaces |
JP2016512839A (ja) | 2013-03-15 | 2016-05-09 | シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. | 治療物質の送達のための生体内分解性ケイ素系組成物 |
US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
US9289461B2 (en) * | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
US10568328B2 (en) | 2013-03-15 | 2020-02-25 | Monsanto Technology Llc | Methods and compositions for weed control |
US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
CA2817728A1 (en) * | 2013-05-31 | 2014-11-30 | Pharmascience Inc. | Abuse deterrent immediate release formulation |
WO2015010026A2 (en) | 2013-07-19 | 2015-01-22 | Monsanto Technology Llc | Compositions and methods for controlling leptinotarsa |
US9850496B2 (en) | 2013-07-19 | 2017-12-26 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
MX368268B (es) * | 2013-10-07 | 2019-09-26 | Bristol Myers Squibb Holdings Ireland | Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih). |
NZ719544A (en) | 2013-11-04 | 2022-09-30 | Beeologics Inc | Compositions and methods for controlling arthropod parasite and pest infestations |
UA119253C2 (uk) | 2013-12-10 | 2019-05-27 | Біолоджикс, Інк. | Спосіб боротьби із вірусом у кліща varroa та у бджіл |
BR112016016337A2 (pt) | 2014-01-15 | 2017-10-03 | Monsanto Technology Llc | Composição e métodos para controlar crescimento, desenvolvimento ou a capacidade de reprodução de uma planta, e para sensibilizar uma planta para um herbicida inibidor de epsps |
ES2544153B1 (es) * | 2014-02-24 | 2016-06-06 | Ntd Labs, S.L. | Uso de un hidrolizado de caseína como agente antiviral |
CN106413390B (zh) | 2014-04-01 | 2019-09-27 | 孟山都技术公司 | 用于控制虫害的组合物和方法 |
KR102596508B1 (ko) | 2014-04-10 | 2023-10-30 | 10엑스 제노믹스, 인크. | 시약을 캡슐화 및 구획화하기 위한 유체 디바이스, 시스템, 및 방법, 및 이의 응용 |
AU2015280252A1 (en) | 2014-06-23 | 2017-01-12 | Monsanto Technology Llc | Compositions and methods for regulating gene expression via RNA interference |
WO2015200539A1 (en) | 2014-06-25 | 2015-12-30 | Monsanto Technology Llc | Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression |
KR20230070325A (ko) | 2014-06-26 | 2023-05-22 | 10엑스 제노믹스, 인크. | 개별 세포 또는 세포 개체군으로부터 핵산을 분석하는 방법 |
EP3167049A4 (de) | 2014-07-08 | 2017-11-29 | MIMEDX Group Inc. | Mikronisierte wharton-sulze |
US20160022604A1 (en) * | 2014-07-23 | 2016-01-28 | Cadila Healthcare Limited | Directly compressed ospemifene compositions |
US10378012B2 (en) | 2014-07-29 | 2019-08-13 | Monsanto Technology Llc | Compositions and methods for controlling insect pests |
WO2016037745A1 (en) * | 2014-09-11 | 2016-03-17 | Gelita Ag | Gelatin/pectin particles |
CN107072212A (zh) * | 2014-09-17 | 2017-08-18 | 龙沙股份有限公司 | 活化的过氧化氢消毒组合物 |
CA2964472A1 (en) | 2014-10-29 | 2016-05-06 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequencing |
US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
TWI713485B (zh) * | 2015-01-06 | 2020-12-21 | 山田修 | 利用燃燒合成材料之醫藥組成物、血液處理裝置、化妝品及飲食品 |
WO2016114970A1 (en) | 2015-01-12 | 2016-07-21 | 10X Genomics, Inc. | Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same |
JP6942632B2 (ja) | 2015-01-22 | 2021-09-29 | モンサント テクノロジー エルエルシー | Leptinotarsa防除用組成物及びその方法 |
WO2016138148A1 (en) | 2015-02-24 | 2016-09-01 | 10X Genomics, Inc. | Methods for targeted nucleic acid sequence coverage |
US10697000B2 (en) | 2015-02-24 | 2020-06-30 | 10X Genomics, Inc. | Partition processing methods and systems |
EP3262233A1 (de) | 2015-02-25 | 2018-01-03 | The Procter and Gamble Company | Faserstrukturen mit einer oberflächenweichmachenden zusammensetzung |
US20160303043A1 (en) * | 2015-04-16 | 2016-10-20 | Kate Somerville Skincare, LLC | Self-foaming compositions and methods |
AU2016270870A1 (en) | 2015-06-02 | 2018-01-04 | Monsanto Technology Llc | Compositions and methods for delivery of a polynucleotide into a plant |
EP3302030A4 (de) | 2015-06-03 | 2019-04-24 | Monsanto Technology LLC | Verfahren und zusammensetzungen zum einführen von nukleinsäuren in pflanzen |
CN107849825A (zh) | 2015-07-10 | 2018-03-27 | 宝洁公司 | 包含复分解不饱和多元醇酯的织物护理组合物 |
EP3882357B1 (de) | 2015-12-04 | 2022-08-10 | 10X Genomics, Inc. | Verfahren und zusammensetzungen zur nukleinsäureanalyse |
WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
EP3481366B1 (de) * | 2016-07-08 | 2022-07-27 | The Gillette Company LLC | Flüssige zusammensetzungen für haarentfernungsvorrichtungen mit metathesierten ungesättigten polyolestern |
DE102016223333A1 (de) * | 2016-11-24 | 2018-05-24 | Henkel Ag & Co. Kgaa | Alkalische Mittel zum Aufhellen von Haaren enthaltend Oxidationsmittel und spezielle Carbonsäureester als Keratinvernetzer |
US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
EP4310183A3 (de) | 2017-01-30 | 2024-02-21 | 10X Genomics, Inc. | Verfahren und systeme zur tröpfchenbasierten einzelzellenbarcodierung |
AU2018227842B2 (en) * | 2017-03-01 | 2024-05-02 | Arena Pharmaceuticals, Inc. | Compositions comprising PGI2-receptor agonists and processes for the preparation thereof |
US10398670B2 (en) * | 2017-04-24 | 2019-09-03 | Knoze Jr. Corporation | Oral microbiota promotion for oral and/or sinus infections |
CN109526228B (zh) | 2017-05-26 | 2022-11-25 | 10X基因组学有限公司 | 转座酶可接近性染色质的单细胞分析 |
US10844372B2 (en) | 2017-05-26 | 2020-11-24 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
US10471033B2 (en) * | 2017-09-15 | 2019-11-12 | Knoze Jr. Corporation | Oral microbiota promotion for immune system associated inflammations |
EP3625361A1 (de) | 2017-11-15 | 2020-03-25 | 10X Genomics, Inc. | Funktionalisierte gelperlen |
US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
CN112262218A (zh) | 2018-04-06 | 2021-01-22 | 10X基因组学有限公司 | 用于单细胞处理中的质量控制的系统和方法 |
JP2022548138A (ja) * | 2019-09-16 | 2022-11-16 | キベルディ インコーポレイテッド | 微生物タンパク質加水分解産物組成物およびその製造方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3764670A (en) * | 1970-10-28 | 1973-10-09 | Ministry Of Agriculture | Polypeptidic anti-biotic substances derived from casein |
US3778426A (en) * | 1970-12-16 | 1973-12-11 | Research Corp | Therapeutically useful polypeptides |
US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
US4959455A (en) * | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
JP2631470B2 (ja) * | 1987-05-15 | 1997-07-16 | 雪印乳業株式会社 | 感染防御剤 |
US5344820A (en) * | 1987-05-15 | 1994-09-06 | Snow Brand Milk Products Co., Ltd. | Infection protectant |
JP2805490B2 (ja) * | 1989-02-07 | 1998-09-30 | 雪印乳業株式会社 | 細菌毒素中和剤 |
US5514646A (en) * | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
FR2686085B1 (fr) * | 1992-01-10 | 1995-08-04 | Agronomique Inst Nat Rech | Peptides representant des fragments du cmp, anticorps diriges contre lesdits peptides, et leurs utilisations. |
GB9310472D0 (en) * | 1993-05-20 | 1993-07-07 | Univ Warwick | Phenylalanine-free protein and dna coding thereof |
TW282398B (de) * | 1993-12-22 | 1996-08-01 | Bristol Myers Squibb Co | |
US5538952A (en) * | 1994-05-26 | 1996-07-23 | Abbott Laboratories | Inhibition of infection of mammalian cells by respiratory syncytial virus |
US5707968A (en) * | 1994-05-26 | 1998-01-13 | Abbott Laboratories | Inhibition of attachment of H.influenzae to human cells |
US5506209A (en) * | 1994-05-26 | 1996-04-09 | Abbott Laboratories | Product for inhibition of infection of mammalian cells by respiratory syncytial virus |
US5712250A (en) * | 1994-09-16 | 1998-01-27 | Abbott Laboratories | Product for inhibition of human rotavirus infection |
KR0140248B1 (ko) * | 1995-03-23 | 1998-06-15 | 한상기 | 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법 |
US5985275A (en) * | 1995-04-12 | 1999-11-16 | New York Blood Center | β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection |
US6570060B2 (en) * | 1995-05-16 | 2003-05-27 | Mclachlan Corran Norman Stuart | Milk lacking β-casein A1 |
KR100221124B1 (ko) * | 1996-09-23 | 1999-10-01 | 한상기 | 신규한 카제인 및 그 제조방법 |
US5830434A (en) * | 1997-02-26 | 1998-11-03 | Medical University Of South Carolina Foundation For Research Development | Methods of treating non-insulin dependent diabetes mellitus with pancreatic polypeptide |
JP4191261B2 (ja) * | 1997-03-21 | 2008-12-03 | 雪印乳業株式会社 | 鉄カゼイン類分解物複合体及びその製造法 |
US6358508B1 (en) * | 1997-06-11 | 2002-03-19 | Human Genome Sciences, Inc. | Antibodies to human tumor necrosis factor receptor TR9 |
PT996726E (pt) * | 1997-08-29 | 2004-04-30 | Brigham & Womens Hospital | Proteina de membrana de celulas t (tirc7) peptidos e anticorpos dela derivados e suas utilizacoes |
AUPP051497A0 (en) * | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
US5985575A (en) * | 1998-05-20 | 1999-11-16 | Wisconsin Alumni Research Foundation | Tethered function assay for protein function |
US6570606B1 (en) * | 1998-05-29 | 2003-05-27 | 3Com Corporation | Method and apparatus for controlling transmission of media signals over a data network in response to triggering events at participating stations |
CA2350911A1 (en) * | 1998-11-16 | 2000-05-25 | Board Of Regents, The University Of Texas System | Hiv-specific t-cell induction |
GB9927603D0 (en) * | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
IL138946A0 (en) * | 2000-10-11 | 2001-11-25 | Compugen Ltd | Method for the identification of peptides and proteins |
WO2007036044A1 (en) * | 2005-09-28 | 2007-04-05 | Dnp Canada Inc. | Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia |
US8865876B2 (en) * | 2008-06-02 | 2014-10-21 | California Institute Of Technology | Engineered lectin oligomers with antiviral activity |
-
2000
- 2000-03-01 IL IL13483000A patent/IL134830A0/xx unknown
-
2001
- 2001-03-01 EA EA200401467A patent/EA007217B1/ru not_active IP Right Cessation
- 2001-03-01 CZ CZ20022915A patent/CZ20022915A3/cs unknown
- 2001-03-01 NZ NZ521016A patent/NZ521016A/en unknown
- 2001-03-01 PL PL36130701A patent/PL361307A1/xx unknown
- 2001-03-01 DK DK01908105.8T patent/DK1261360T3/da active
- 2001-03-01 HU HU0301003A patent/HUP0301003A3/hu unknown
- 2001-03-01 EA EA200200820A patent/EA005579B1/ru not_active IP Right Cessation
- 2001-03-01 MX MXPA02008569A patent/MXPA02008569A/es not_active Application Discontinuation
- 2001-03-01 WO PCT/IL2001/000198 patent/WO2001064234A1/en active IP Right Grant
- 2001-03-01 CN CN01808959A patent/CN1427725A/zh active Pending
- 2001-03-01 DE DE60140794T patent/DE60140794D1/de not_active Expired - Lifetime
- 2001-03-01 AT AT01908105T patent/ATE451929T1/de not_active IP Right Cessation
- 2001-03-01 AU AU35962/01A patent/AU782662B2/en not_active Ceased
- 2001-03-01 JP JP2001563131A patent/JP2003528827A/ja active Pending
- 2001-03-01 EP EP01908105A patent/EP1261360B1/de not_active Expired - Lifetime
- 2001-03-01 BR BR0109027-5A patent/BR0109027A/pt not_active IP Right Cessation
- 2001-03-01 CA CA002401550A patent/CA2401550A1/en not_active Abandoned
- 2001-08-30 US US09/942,121 patent/US20020147144A1/en not_active Abandoned
-
2002
- 2002-08-19 IL IL151351A patent/IL151351A/en active IP Right Grant
- 2002-08-27 ZA ZA200206842A patent/ZA200206842B/en unknown
- 2002-08-29 EA EA200400376A patent/EA007814B1/ru not_active IP Right Cessation
- 2002-08-30 NO NO20024157A patent/NO20024157L/no not_active Application Discontinuation
- 2002-08-31 KR KR10-2002-7011450A patent/KR20030025907A/ko not_active Application Discontinuation
-
2006
- 2006-09-08 US US11/518,400 patent/US7741274B2/en not_active Expired - Lifetime
-
2007
- 2007-10-31 US US11/982,369 patent/US20090192081A1/en not_active Abandoned
-
2010
- 2010-04-22 US US12/764,996 patent/US20100298216A1/en not_active Abandoned
- 2010-07-28 US US12/844,834 patent/US20100317601A1/en not_active Abandoned
-
2012
- 2012-09-05 US US13/603,428 patent/US8735348B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60140794D1 (de) | Von casein abgeleitete peptide und deren anwendung für die therapie | |
WO2005081628A3 (en) | Casein derived peptides and therapeutic uses thereof | |
DE69841982D1 (de) | Zusammensetzungen zum einsatz in einer gentherapie zur behandlung von hämophilie | |
ATE198050T1 (de) | Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia | |
ATE242633T1 (de) | Dialkylfumarate zur behandlung von autoimmunerkrankungen | |
DE69838986D1 (de) | Polypeptide, deren herstellung und verwendung | |
ATE63748T1 (de) | Enzymwiderstandsfaehige immunomodulatorische peptide. | |
DE69719754D1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
KR20040078639A (ko) | 카세인 유도 펩타이드 및 이들의 치료 용도 | |
MXPA05008704A (es) | Proteinas de fusion de muteinas de interferon alfa con propiedades mejoradas. | |
NZ508505A (en) | Treatment of wounds using an Egr-1 transcription factor polypeptide | |
DE69833876D1 (de) | Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren | |
NO971247D0 (no) | Defektive, rekombinante adenoviruser med inaktivt IVa2-gen | |
TR199902866T2 (xx) | Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlar�, haz�rlanmalar� ve terapide kullan�lmalar� i�in prosesler. | |
ATE405286T1 (de) | Neue mittel zur linderung von motorischen störungen | |
DE3769497D1 (de) | Mittel zur bekaempfung von phytopathogenen mikroben. | |
CA2163805A1 (en) | Novel activating factor of leukocytes | |
CA2184297A1 (fr) | Virus recombinants codant pour une activite glutamate decarboxylase (gad) | |
WO2024040030A3 (en) | Treating protein misfolding disorders | |
DE60116466D1 (de) | Myeloider koloniestimulierungsfaktor und verwendungen davon | |
ES2188754T3 (es) | Componente b como cicatrizante. | |
MX9703191A (es) | Anticuerpos contra proteinas alogenicas y xenogenicas, su uso en diagnostico y terapia y metodos para la determinacion de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |